Paylocity Is Running Warm Into Its Own Earnings

Paylocity (PCTY) has gone from the low $140s to $169 this year, and if you blinked during the summer you missed most of it. It's up 16% over the last month, up 40% over the last quarter, and sitting just under its 52-week high near $171.53. That's a lot of stock to own and feel nothing as it climbs. It's also exactly how you get caught sleeping when it doesn't.

Let's start with what the business actually is, because the numbers are genuinely good. Fiscal 2026 closed on roughly $1.8 billion in revenue, up 11% year over year. GAAP net income jumped 18.8% to $269.7 million. Adjusted EBITDA margin expanded to 37%. Free cash flow hit $427.8 million — comfortably above net income, which is the kind of quality that gets overlooked in a quiet HR/payroll software company until it doesn't. Balance sheet looks like a fortress: $272 million cash against $133 million in debt, debt-to-equity of 0.11, ROIC around 20%. They've bought back about $700 million of stock since May 2024 and just got another $1 billion of authorization. This is a company that compounds.

Now the part that should make you sit up.

The deceleration is the story, and nobody wants to read it. Management guided fiscal 2027 revenue growth at roughly 7% — about half the fiscal 2026 pace. Recurring revenue up 8%. And here's the uncomfortable detail: client base growth slowed to roughly 7% while top-line growth was 11%. That gap is the entire bull case and the entire bear case in one sentence. It means the growth coming in is increasingly from selling more to people who already buy, not from winning new logos. That works until it doesn't. There's a depth to that well, and it's shallower than the tape assumes.

Then there's the margin story, which deserves a skeptical eye. Starting fiscal 2027, Paylocity is extending its deferred contract-cost amortization from seven to eight years. Management says that alone lifts adjusted EBITDA margin by 120 to 140 basis points. That's not new business. That's an accounting shift making the P&L look better by spreading a cost over more periods. Real cash is still being made, but a chunk of that 37% margin expansion is a book entry, not a pricing win.

And the gap between what they report and what they don't is worth staring at: fiscal 2026 GAAP operating income was $386 million versus non-GAAP operating income of $557 million. That's a $170 million spread on costs the company insists don't count. Stock-based compensation, mostly. It always comes back eventually.

So where does that leave us? Rich, but not absurdly so, on the forward numbers. The stock trades at a trailing P/E of 34.3x and a P/S near 5x — genuinely expensive on the past. But at a forward P/E of roughly 17.4x, the market is telling you it expects growth to slow, and it's pricing for that. Not a bargain, but a coherent one. Short float sits at about 7%, which isn't a squeeze waiting to happen and isn't a death spiral either. Just a stock people are willing to bet against.

The technicals are where I'd reach for the brakes, not the gas. Price is about 16% above its 20-day moving average. Relative strength is at 77.6 — overbought, past the point of "healthy" into the zone where Benzinga already flagged it among overbought names. This is a vertical leg off the June lows, and vertical legs tend to kink. The smart money has noticed: on October 15 alone, the chairman and several directors — including Sarowitz — dumped shares in a clustered sell, with more coming on the 16th and 19th. Insider selling is noise more often than signal, but a whole management team cashing out right at the highs, right into an overbought tape, is not a shrug-worthy thing.

Note that a couple of analysts got constructive — Citizens jumped to a Market Outperform with an $180 target, Barclays raised to $162. That's the counterweight. But raised targets and overbought mechanics can coexist; the targets are for the long game, the tape is for right now.

Here's my read. Paylocity is a high-quality compounder facing a legitimate growth deceleration, trading at a valuation that only makes sense if you believe the AI initiatives — Ignite, the Grayscale recruiting acquisition, the Elevate managed service — actually convert to revenue instead of living as press releases. That's a "maybe," not a "definitely." And the near-term setup is crowded and stretched into a binary event: Q1 FY2027 earnings land November 5, after the close — a little over two weeks out.

I'm not going to chase $171 with RSI near 78 and an earnings report hanging over the whole thing. That's not conviction; that's FOMO with a ticker. If I want in, I want weakness. A pullback toward the $158 to $160 area — the breakout retest, the place overbought buyers would add on a sane tape — is far more interesting than the highs. Hold $150 as the next floor, and $143 as the level that, if broken, changes the whole thesis. A decisive close above $171.53 on volume would be the only thing making me regret not chasing — that opens $180.

The honest conclusion: this is a great company at a demanding price, in an overbought technical posture, heading straight at a earnings catalyst I can't predict. The market has already priced the deceleration into a reasonable forward multiple, which cuts both ways — it means downside may be cushioned, and upside needs a beat. So I'll wait for the tape to calm down and let November 5 do the talking. You don't have to own the breakout. You never have to buy anything at the top of a vertical leg. Paylocity will still be there next quarter, decelerating or not.